Naveris, Inc.

📍 Waltham, United States👥 117 employees💰 Last funded Feb 2024
Biotechnology Research🌐 naveris.com
Website LinkedIn
Naveris® Inc. is a molecular diagnostics company developing and commercializing novel blood and saliva tests to enhance the early detection and clinical management of viral-associated cancers. The company’s NavDx® blood test, which uses proprietary technology to detect tumor tissue modified viral (TTMV®)-HPV DNA, is in use at leading cancer treatment centers and academic medical centers throughout the United States. www.naveris.com www.navdx.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Naveris, Inc.?
Naveris, Inc. has 1 investors on record on gritt.io.
When did Naveris, Inc. last raise funding?
The most recent investment in Naveris, Inc. recorded on gritt.io was in February 2024.
What industry is Naveris, Inc. in?
Naveris, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Naveris, Inc. based?
Naveris, Inc. is headquartered in Waltham, United States.